This website uses cookies to improve your user experience.
By using the site, you agree to our use of cookies.
Click here for more information about how we use cookies.
We are delighted to announce the winner of the 2024 EACR - Molecular Oncology Editorial Fellowship is Yeliz Yilmaz (Izmir Biomedicine and Genome Center, Turkey).
The aim of this funding is to provide an opportunity to gain knowledge and experience of scientific publishing through a short-term fellowship with the FEBS journal Molecular Oncology. The winner will spend 3 months working remotely as part of the Molecular Oncology editorial team, and have the chance to visit the Molecular Oncology Editorial Office in Heidelberg.
Skills to be developed: The Fellowship aims to develop the applicant’s skills in the areas of the editorial process and scientific writing. During the first month of the fellowship, the successful applicant will engage remotely with the Editorial Office team to get familiar with all aspects of publishing, including a first evaluation of new submissions, admin checks on manuscripts, editorial checks on provisionally accepted articles, writing of article highlights for the journal website and the FEBS Network, and assisting Section Editors with finding potential reviewers.
After the second month of their fellowship, the successful applicant can start joining Editorial Status Meetings, and become involved in article commissioning and the developmental editing of Review articles and front-half material. The successful applicant will also have an opportunity to visit the Editorial Office in Heidelberg and exchange in person on all matters pertaining to the daily editorial routine.
Yeliz Yilmaz is currently working as a postdoc at Izmir Biomedicine and Genome Center in Turkey. After receiving Bachelor’s and Master’s degrees from the Department of Molecular Biology and Genetics in Boğaziçi University, she moved to Dokuz Eylul University and started her PhD in the field of cancer biology.
Under the supervision of Professor Nese Atabey, she could combine her long-time passion, metabolism, with cancer. She was eager to investigate the mechanisms behind obesity-related hyperinsulinemia in the promotion of tumour progression and aggression. During her PhD, she had the chance to visit and benefit from the scientific environments of Eggeling Lab (Oxford University, UK) and Estall Lab (IRCM, Canada).
After completing her doctoral studies, she started working as a postdoc in a joint collaborative project of Atabey Lab and Desbois-Mouthon Lab (INSERM-Paris, France). She continued to study the role of insulin receptor isoforms in receptor crosstalk and the perturbated signalling in cancer. Moreover, she was enthusiastic about suggesting a mechanistic perspective of the post-translational modification, neddylation, in the development and progression of hepatocellular carcinoma. Like many researchers, her long-time ambition is to see her studies to be translated to cancer therapy as a part of personalised treatment alternatives.
Above: 2024 winner Yeliz Yilmaz